PHARMAZEUTISCHER PROZESS

European patent · EP3217965 · In force

Register entry

Publication number
EP3217965
Application number
EP15797174
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 16, 2015
Published
Sep 20, 2017
Granted
Apr 24, 2024
Protection ends at the latest
Nov 15, 2035
Next annual fee due
Nov 30, 2026
IPC classes
A61K 9/28 (2006.01)
A61K 9/20 (2006.01)
A61K 31/00 (2006.01)
Priority
GB 201420311 14.11.2014
PCT application
PCT/GB2015/053472 16.11.2015
PCT publication
WO2016/075496 19.05.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 5, 2025

    Change

    Published in Swissreg on 05.12.2025

  2. Mar 5, 2025

    Change

    Published in Swissreg on 05.03.2025

  3. Dec 9, 2024

    Change

    Published in Swissreg on 09.12.2024

  4. Jul 18, 2024

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 18.07.2024

  5. Apr 24, 2024

    Granted

    Published in Swissreg on 24.04.2024

Parties

Holder

Drug Delivery International Ltd

Basement Medical Block Within Glasgow Royal Infirmary 84 Castle Street, Glasgow, Strathclyde G4 0SF, GB

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

BHARDWAJ, Vivekanand

Zionsville, Indiana 46077, US

STEVENS, Howard Norman Ernest

Larkhall Strathclyde ML9 3BN, GB

MULLEN, Alexander Balfour

East Kilbride Strathclyde G74 2HE, GB

MACDOUGALL, Fiona Jane

Bishopbriggs Strathclyde G64 1ET, GB

SMITH, David

North Lanarkshire Strathclyde ML7 4AX, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.